Clinical Trial Update: Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers [Phase 1]

View source ↗

Summary

A Phase 1 study using concurrent D2/D3 receptor PET imaging and fMRI during smoking cue exposure in nicotine-dependent individuals has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Relapse to Smoking

Snippet

Sponsor: Mclean Hospital | Conditions: Nicotine Dependence, Smoking Cue Reactivity | Phase 1 | Status: WITHDRAWN